Overview
- 267 inspections across 253 sites are on record.
- 744 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-21.
At a glance
Inspections
267
Sites
253
Observations
744
Career since
Jul 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Kedrion Biopharma Inc. | 21 May 2026 | Biologics | View 483 → |
| StemCyte, Inc | 24 Mar 2026 | Biologics | View 483 → |
| Fenwal International, Inc. | 5 Feb 2026 | Biologics | View 483 → |
| MassBiologics | 18 Dec 2025 | Biologics | View 483 → |
| Juno Therapeutics, Inc. | 4 Nov 2025 | Biologics |
Sites inspected
Kedrion Biopharma Inc.Melville, United States1 insp.
StemCyte, IncBaldwin Park, United States1 insp.
Fenwal International, Inc.Maricao, United States1 insp.
MassBiologicsBoston, United States1 insp.
Juno Therapeutics, Inc.Bothell, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Lauren E Skokan7 shared
Gene D Arcy6 shared
Alan L Truong4 shared
Brian R Yaun4 shared
Saleem A Akhtar4 shared
Ashley N Williams4 shared
Tricia S Martinez4 shared
Matthew R Noonan3 shared
Christopher J Adams3 shared
Travis S Bradley3 shared
Full investigator report
Get the verbatim findings behind Scott T Ballard's 744 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site